Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21180630 | 0.88 | PGR (0.34) | — | |
| SCHEMBL15460282 | 0.86 | APP (0.33) | APPCYP2C9KDM1AERN1MAOB | |
| SCHEMBL15460198 | 0.85 | PRKDC (0.36) | APPCYP2C9KDM1AERN1MAOB | |
| SCHEMBL15460329 | 0.84 | MAPT (0.33) | APPCYP2C9KDM1AERN1MAOB | |
| SCHEMBL15912249 | 0.84 | KDM4E (0.33) | PRKCBPRKCAPRKCHPRKCEPRKCQ | |
| SCHEMBL15460246 | 0.83 | PRKDC (0.33) | APPCYP2C9KDM1AERN1MAOB | |
| SCHEMBL14725798 | 0.82 | ALOX5 (0.42) | MAPTPRKDC | |
| SCHEMBL14725797 | 0.79 | ALOX5 (0.36) | MAPT | |
| SCHEMBL14725783 | 0.79 | APP (0.34) | APPCYP2C9ERN1PRKDC | |
| SCHEMBL14725777 | 0.76 | CYP11B1 (0.39) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255084-B2 | Heterocyclic compound and organic light-emitting device containing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-09 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | TRPC1, TRPC4, TRPC6 | APP 271/4885CYP2C9 152/4885KDM1A 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.